SANUWAVE Health financials
$4.74+1.94%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $44.1M |
| Gross profit | $34.0M |
| Gross margin | 77.1% |
| Operating income | $4.9M |
| Net income | $11.8M |
| Net margin | 26.8% |
| Diluted EPS | $0.41 |
| EBITDA | $5.9M |
| Operating cash flow | $3.9M |
| Free cash flow | $1.9M |
| Diluted shares | 9.1M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $12.0M |
| Short-term investments | $0.00 |
| Total debt | $22.0M |
| Total assets | $37.3M |
| Total liabilities | $35.7M |
| Shareholders' equity | $1.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology